Literature DB >> 21429008

Diabetes prevalence based on health insurance claims: large differences between companies.

F Hoffmann1, A Icks.   

Abstract

AIMS: We investigated if there are substantial differences in the prevalence of diabetes between members of different health insurance funds in Germany and, if so, which variables might explain these differences.
METHODS: Ten representative surveys (conducted between 2004 and 2008) of the Bertelsmann Healthcare Monitor, comprising 15 089 participants aged 18-79 years, were analysed. Our main independent variable was membership in one of eight health insurance funds. We first estimated the crude prevalence of diabetes stratified by these funds. We further fitted logistic regression models and stepwise adjusted for age and sex, further co-morbidities and anthropometric measures and factors influencing health awareness and lifestyle.
RESULTS: The overall prevalence of diabetes was 6.9%. Stratified by health insurance funds, prevalences ranged between 3.9% within the Innungskrankenkassen to 11.4% within the Allgemeine Ortskrankenkassen. Adjusting for age and sex only led to minor changes. After controlling for all mentioned variables, these differences remained. Compared with those who were privately insured, persons within the Allgemeine Ortskrankenkassen (OR 1.73; 95% CI 1.30-2.29), the Betriebskrankenkassen (OR 1.54; 95% CI 1.15-2.07) and the Barmer (OR 1.39; 95% CI 1.01-1.91) had a higher prevalence.
CONCLUSIONS: We found considerable differences in diabetes prevalence between German health insurance funds that remained after controlling for several relevant variables.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Year:  2011        PMID: 21429008     DOI: 10.1111/j.1464-5491.2011.03305.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  22 in total

1.  [Prescription of TNF-alpha inhibitors and regional differences in 2010].

Authors:  R Windt; G Glaeske; F Hoffmann
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

2.  [Differences in chronic back pain and joint disorders among health insurance funds : Results of a cross-sectional study based on the data of the Socioeconomic Panel from 2013].

Authors:  A Luque Ramos; F Hoffmann
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

3.  Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.

Authors:  Ingrid Schubert; Peter Ihle; Rainer Sabatowski
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

4.  Institutionalization in incident dementia cases in comparison to age- and sex- matched controls: a 5-year follow-up from Germany.

Authors:  Jana Schulze; Hendrik van den Bussche; Hanna Kaduszkiewicz; Daniela Koller; Falk Hoffmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-08       Impact factor: 4.328

5.  Adjusting selection bias in German health insurance records for regional prevalence estimation.

Authors:  Ralf Thomas Münnich; Jan Pablo Burgard; Joscha Krause
Journal:  Popul Health Metr       Date:  2019-08-27

Review 6.  Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.

Authors:  Wolfgang Rathmann; Christa Scheidt-Nave; Michael Roden; Christian Herder
Journal:  Dtsch Arztebl Int       Date:  2013-05-10       Impact factor: 5.594

7.  Prevalence, comorbidities and outpatient treatment of anorexia and bulimia nervosa in German children and adolescents.

Authors:  Charlotte Jaite; Falk Hoffmann; Gerd Glaeske; Christian J Bachmann
Journal:  Eat Weight Disord       Date:  2013-04-16       Impact factor: 4.652

8.  Renal Replacement Therapy in People With and Without Diabetes in Germany, 2010-2016: An Analysis of More Than 25 Million Inhabitants.

Authors:  Heiner Claessen; Maria Narres; Tatjana Kvitkina; Adrian Wilk; Heiko Friedel; Christian Günster; Falk Hoffmann; Michael Koch; Karin Jandeleit-Dahm; Andrea Icks
Journal:  Diabetes Care       Date:  2021-05-04       Impact factor: 17.152

9.  Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany.

Authors:  Andrea Icks; Heiner Claessen; Stephan Morbach; Gerd Glaeske; Falk Hoffmann
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

10.  [Epistaxis and anticoagulation therapy: an analysis based on health insurance data from Lower Saxony].

Authors:  A E Althaus; U Arendt; F Hoffmann; J Lüske; M H Freitag; K Jobski; M Dörks
Journal:  HNO       Date:  2021-03       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.